Latisse Ophthalmic Solution (Bimatoprost 0.03%)

Latisse Ophthalmic Solution is a prescription topical treatment built around bimatoprost 0.03%, a prostaglandin-related compound long studied for its effect on hair follicle activity. We offer it as a single-strength ophthalmic solution in bottle counts of one, two, three, four, and six, so customers can match a package to how long they plan to use it. Applied nightly along the upper eyelid margin with the accompanying applicator, Latisse is intended to gradually grow eyelashes that are thin, sparse, or shorter than desired. The sections below walk through how it works, how it is used, what to watch for, and how it relates to other bimatoprost-based treatments.

What Latisse Is and Why We Carry It

Latisse Ophthalmic Solution is the branded formulation of bimatoprost 0.03%, packaged specifically for upper-eyelid-margin application rather than routine dosing into the eye. It is manufactured by Allergan Pharmaceuticals Ireland. We carry Latisse as a dedicated ophthalmic solution intended for eyelash hypotrichosis, allowing customers to order the formulation designed for this purpose rather than a bimatoprost product packaged and labeled for lowering intraocular pressure.

Understanding Eyelash Hypotrichosis

Hypotrichosis of the eyelashes refers to having an inadequate number, length, or thickness of lashes, whether from natural variation, aging, or prior eyelash loss. It is a condition that primarily affects appearance and confidence rather than eye health itself. Latisse is formulated to address this specific concern by working directly at the base of each eyelash rather than by covering or extending existing lashes the way cosmetics do.

How Bimatoprost Works at the Eyelash Follicle

Bimatoprost is structurally related to prostaglandin F2α and acts on prostamide-sensitive pathways within the hair follicle. When applied to the eyelid margin, it appears to increase the proportion of eyelash hairs in the anagen, or active growth, phase, while also extending how long that growth phase lasts. It is also associated with an increase in the size of the hair follicle and greater melanin production in the hair shaft, which is why lashes tend to look not only longer but fuller and darker with consistent use. This is predominantly a localized follicular effect, which is why the medicine is applied directly at the lash line instead of taken orally.

What the Clinical Evidence Shows

Bimatoprost 0.03% for eyelash growth was evaluated in a randomized, double-masked, vehicle-controlled, multicenter trial lasting 16 weeks. In the pivotal trial, approximately 78% of participants using bimatoprost had at least a one-grade improvement in overall eyelash prominence by week 16, compared with approximately 18% of participants using the vehicle. Digital image analysis also documented average increases in eyelash length, fullness, and darkness. Some users begin noticing changes after about four weeks, but the effect generally continues to build through the 16-week mark. Continued use is needed to maintain the improvement; after treatment stops, eyelashes gradually return toward their previous appearance.

Formulation and Ingredients

Latisse Ophthalmic Solution contains bimatoprost 0.03% as its active ingredient in a sterile aqueous solution for application to the upper eyelid margin. Its inactive ingredients include benzalkonium chloride as a preservative, sodium chloride, sodium phosphate dibasic, citric acid, and purified water, with sodium hydroxide or hydrochloric acid used to adjust pH. The supplied sterile applicators are intended to deliver a controlled amount along the base of the upper lashes. A separate applicator should be used for each eye and discarded after use to reduce contamination risk.

Approved Use and Who Latisse Is For

Latisse is indicated for the treatment of hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness. It is intended for adults who want to improve the appearance of their upper eyelashes and are able to apply it consistently as part of a nightly routine. It is not interchangeable with bimatoprost products dosed into the eye for elevated intraocular pressure, even when the active ingredient and concentration are the same, because the indication, application method, packaging, and dosing instructions may differ.

Strength, Package Sizes, and General Application Guidelines

We offer Latisse Ophthalmic Solution in a single strength, 0.03%, and in packages of one, two, three, four, or six bottles, letting customers choose a supply that matches how long they plan to use it. Latisse is applied once nightly. After removing contact lenses and cleaning the face of makeup, place one drop on a sterile applicator and draw it along the skin of one upper eyelid margin at the base of the lashes, from the inner to the outer corner, similar to applying eyeliner. Blot away any excess beyond the eyelid margin, discard the applicator, and repeat on the other upper eyelid with a new sterile applicator. Only the upper lash lines are treated; the solution is not intended for the lower lids. Applying it more than once nightly does not speed up or improve results and may increase unwanted effects, so consistency rather than extra applications drives outcomes.

Elimination and Half-Life

Systemic exposure to bimatoprost is low after topical ophthalmic administration. Pharmacokinetic studies of dosing to the eye found low blood concentrations that generally fell below the limit of detection within about 1.5 hours after a dose. When bimatoprost has been administered intravenously for pharmacokinetic study, its elimination half-life has been approximately 45 minutes. It undergoes oxidation, N-deethylation, and glucuronidation, with metabolites eliminated through urinary and fecal routes. These findings support the low systemic exposure expected with correct eyelid-margin use, although local effects around the treated eye can still occur.

Important Safety Information

Latisse is intended for the skin of the upper eyelid margin and should not be applied directly into the eye, on the lower lash line, or to broken or irritated skin. People with eye-pressure problems, prior eye surgery, macular-edema risk factors, or ongoing intraocular inflammation should discuss use with a prescriber first. Contact lenses should be removed before application because the preservative can be absorbed by soft lenses; they may generally be reinserted after 15 minutes. Lashes, eyelid pigmentation, or hair growth may become uneven if the solution is applied inconsistently or repeatedly reaches nearby skin. Anyone noticing unexpected vision changes, eye pain, marked inflammation, or signs of infection should seek medical advice.

Prescription Status and Ordering With Us

Bimatoprost is authorized for human medicinal use in the United States, and Latisse Ophthalmic Solution is a prescription medicine. That legal classification is separate from the information or documentation our checkout may require to accept a particular order. Contact our pharmacist-supported team to confirm the current ordering requirements before purchasing. Our team is available 24/7 by phone, email, and online chat to answer questions, help confirm the appropriate offered package quantity, and coordinate packing and dispatch once everything required for an order is in place. Drugs-24h has been operating since 2008, and our support staff can guide US customers through the ordering process from start to finish.

Who Should Avoid Latisse or Seek Advice First

The US prescribing information lists no formal contraindications for Latisse, but anyone with a known hypersensitivity to bimatoprost or another ingredient should not use it. People with active eye infections, intraocular inflammation, or prior intraocular surgery should speak with a prescriber before starting treatment. Bimatoprost should be used cautiously in people with known risk factors for macular edema, including aphakia, pseudophakia with a torn posterior lens capsule, or diabetic macular disease. Safety and effectiveness have not been established in pediatric patients. During pregnancy, it should be used only when a prescriber determines that the potential benefit justifies the potential fetal risk. Caution is also advised while breastfeeding because it is not known whether topical ophthalmic bimatoprost produces detectable levels in human milk.

Interactions With Other Medicines and Eye Products

Systemic drug interactions are unlikely because exposure after eyelid-margin application is low. However, people using bimatoprost or another prostaglandin analog inside the eye to lower intraocular pressure should consult their prescriber before starting Latisse. Concurrent use of more than one prostaglandin analog may interfere with the intended pressure-lowering response, and intraocular pressure may need to be monitored. If other topical eye medicines are prescribed, follow the prescriber's instructions about spacing and order of administration. Cosmetics or skin products that irritate the eyelid margin may also make local reactions harder to identify, so introducing several new products at the same time is best avoided.

Side Effects: Common Reactions and When to Seek Help

The most frequently reported effects with Latisse are itchy eyes and redness of the white part of the eye, known as conjunctival hyperemia. Other possible local effects include dry eye, irritation, eyelid redness, darkening of the skin along the application area, and a foreign-body sensation. Eyelid skin darkening may lessen after the product is stopped. Hair can also grow on nearby skin that is repeatedly exposed to the solution, which is why excess should be blotted away.

A distinct and potentially permanent effect is increased brown pigmentation of the iris. This has been documented most clearly when bimatoprost is placed directly into the eye, but it remains a possible risk when the medicine is used around the eye. Changes may be more noticeable in people with mixed-color irises, such as hazel, green-brown, or blue-gray eyes. Anyone who experiences eye pain, sudden vision changes, significant swelling, discharge suggestive of infection, or a suspected allergic reaction should stop using Latisse and seek prompt medical attention.

Overdose and Accidental Exposure

Applying more Latisse than directed or using it more than once nightly will not improve or speed results and mainly raises the likelihood of local irritation or hair growth outside the intended area. Blot excess solution away rather than reapplying it. Latisse is an ophthalmic solution, so if a small amount enters the eye accidentally, it does not normally need to be rinsed out. Seek medical advice if significant or persistent pain, redness, irritation, or vision changes follow the exposure. If the solution is swallowed, contact Poison Control at 1-800-222-1222 for case-specific advice; call emergency services immediately for severe symptoms.

Storage and Handling

Store Latisse Ophthalmic Solution at 36°F to 77°F, with the bottle tightly closed between uses and protected from contamination. Keep it out of reach of children and pets, and do not use it beyond the labeled expiration date. Do not let the bottle tip touch the fingers, applicator surface, eye, eyelid, or surrounding skin. Applicators are for single use and should not be shared or reused, both to protect sterility and to avoid cross-contamination.

Benefits and Trade-Offs to Weigh

The main appeal of Latisse is that it acts on the biology of the eyelash follicle itself, offering a route to longer, fuller, and darker lashes that goes beyond the temporary appearance provided by mascara or lash extensions. Its effect is supported by controlled clinical evidence, and once-nightly application can fit into a regular evening routine. The trade-offs are largely about time, consistency, and safety: visible change generally takes weeks, the effect builds over about 16 weeks, and continued use is needed to maintain the improvement. Local irritation and pigment changes are possible, hair can grow where excess solution repeatedly touches the skin, and increased iris pigmentation may be permanent. Latisse is also a prescription medicine, adding a clinical step that purely cosmetic lash products do not have.

Latisse, Generic Bimatoprost, and Other Prostaglandin Analogs

Latisse and generic bimatoprost products contain the same active ingredient, but they are not automatically interchangeable for eyelash growth. Many generic bimatoprost ophthalmic solutions are packaged and labeled for administration into the eye to reduce elevated intraocular pressure and may not include the sterile eyelid applicators or eyelash-specific instructions supplied with Latisse. A bimatoprost product should be applied to the eyelid margin only when a prescriber has specifically directed that use.

Other prostaglandin analogs used for glaucoma or ocular hypertension, including latanoprost, travoprost, and tafluprost, share some pharmacologic features with bimatoprost but are not approved as cosmetic eyelash-growth substitutes for Latisse. Nonmedicine alternatives such as mascara, false lashes, or extensions can change appearance immediately but do not prolong the natural eyelash growth phase and have their own irritation and maintenance considerations. If you are also managing a broader eye care need, you can browse our Eye Care selection alongside the information about Latisse.